An NMR study of cyclodextrin complexes of the steroidal neuromuscular blocker drug Rocuronium Bromide

Magnetic Resonance in Chemistry

Volumn 40, Issue 4, 2002, Pages 251-260

  Cameron, Kenneth S ^a   Fletcher, Dan ^a   Fielding, Lee ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

13C NMR; 1H NMR; Anaesthetics; Cyclodextrins; Host guest chemistry; NMR; Steroids

Indexed keywords

ANESTHETICS; CHEMICAL SHIFT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

13C NMR; 1H NMR; BINDING CONSTANT; CYCLODEXTRIN COMPLEXES; HOSTGUEST CHEMISTRY; NMR EXPERIMENTS; NMR STUDIES; ROCURONIUM; SOLUTION STATE NMR; STEROID;

CYCLODEXTRINS;

BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT; ORG 25969; ROCURONIUM;

ARTICLE; BINDING AFFINITY; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; CROSS LINKING; DRUG BINDING; NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; STOICHIOMETRY;

EID: 0042316458     PISSN: 07491581     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrc.1008     Document Type: Article

References (33)

1. Katz RL (ed.). Muscle Relaxants, Monographs in Anaesthesiology, Vol. 3. Elsevier: New York, 1975.
2. Rees DC, Hill DR. Annu. Rep. Med. Chem. 1996; 31: 41.
3. Szpilfogel SA, Zeelen FJ. Steroids 1996; 61: 483.
4. Zhang M, Palin R, Bennett DJ. Akzo Nobel. Patent WO2001-40316-A1.
5. Wallimann P, Marti T, Fürer A, Diederich F. Chem. Rev. 1997; 97: 1567.
6. Connors KA. Chem. Rev. 1997; 97: 1325.
7. Schneider H-J, Hacket F, Rüdiger V, Ikeda H. Chem. Rev. 1998; 98: 1755.
8. Jackson K, Young D, Pant S. Pharmaceut. Sci. Technol. Today 2000; 3: 336.
9. Hamasaki K, Ikeda H, Nakamura A, Ueno A, Toda F, Suzuki I, Osa T. J. Am. Chem. Soc. 1993; 115: 5035.
10. Bügler J, Engbergsen JFJ, Reinhoudt DN. J. Org. Chem. 1998; 63: 5339.
11. Sato M, Narita M, Ogawa N, Hamada F. Anal. Sci. 1999; 15: 1199.
12. De Jong MR, Engbergsen JFJ, Huskens J, Reinhoudt DN. Chem. Eur. J. 2000; 6: 4034.
13. Uekama K, Fujinaga T, Hirayama F, Otagari M, Yamasaki M. Int. J. Pharm. 1982; 10: 1.
14. Liu F-Y, Kildsig DO, Mitra AK. Pharmaceut. Res. 1990; 7: 869.
15. Djedaini F, Perly B. J. Pharmaceut. Sci. 1991; 80: 1157.
16. Badawy SIF, Marshall AL, Ghorab MM, Adeyeye CM. Drug Dev. Ind. Pharm. 1996; 22: 959.
17. Tan X, Lindenbaum S. Int. J. Pharm. 1991; 74: 127.
18. Tan ZJ, Zhu XX, Brown GR. Langmuir 1994; 10: 1034.
19. Vandelli MA, Salvioli G, Mucci A, Panini R, Malmusi L, Forni F. Int. J. Pharm. 1995; 118: 77
20. Mucci A, Vandelli MA, Salvioli G, Malmusi L, Forni F, Schenetti L. Supramol. Chem. 1996; 7: 125.
21. Yim CT, Zhu XX, Brown GR. J. Phys. Chem. B 1999; 103: 597.
22. Mucci A, Schenetti L, Vandelli MA, Forni F, Ventura P, Salvioli G. J. Chem. Soc. Perkin Trans. 2 1996; 2347.
23. Cabrer PR, Alvarez-Parrilla E, Meijide F, Seijas JA, Núnez ER, Tato JV. Langmuir 1999; 15: 5489.
24. Chun IK, Yun DS. Int. J. Pharm. 1993; 96: 91.
25. Fielding L. Tetrahedron 2000; 56: 6151.
26. Fielding L. Magn. Reson. Chem. 1998; 36: 387.
27. Gil VMS, Oliverira NC. J. Chem Educ. 1990; 67: 473.
28. Foster R, Fyfe CA. Prog. Nucl. Magn. Reson. Spectrosc. 1969; 4: 1.
29. Hanna MW, Ashbaugh AL. J. Phys. Chem. 1964; 68: 811.
30. Cameron KS, Fletcher D, Fielding L. Submitted to Magn. Reson. Chem.
31. Ohta Y. Acta Med. Okayama 1985; 39: 471.
32. Fielding L, Grant G. J. Am. Chem. Soc. 1991; 113: 9785.
33. Fielding L, Grant G. J. Am. Chem. Soc. 1993; 115: 1902.